Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
Recombinant human erythropoietin has been available for clinical use since 1985. It was an immediate success in treating the anemia of chronic renal failure and has also enjoyed some objective ...
deficiency. Recombinant human erythropoietin (r-hEPO) corrects the anemia of chronic renal disease and improves patient well-being, exercise tolerance, and cognitive function. The clinical pharmacology ...
an overview of the state of the art use of rhEPO in anemic patients and will discuss future developments. Recombinant human erythropoietins (rhEPO) reliably increase hemoglobin levels in cancer patients ...
The introduction of recombinant human erythropoietin (RHuEPO) has revolutionised the treatment of patients with anaemia of chronic renal disease. Clinical studies have demonstrated that RHuEPO ...
with potential clinical usefulness . Rev Infect Dis 1990 ; 12 : 41 – 62 . Google Scholar Crossref Search ADS PubMed WorldCat 4 Vadhan-Raj S. , Keating M., LeMaistre A., et al. Effects of recombinant human ...
erythropoietin levels, and bone marrow erythroid hypoplasia. The recent availability of recombinant human erythropoietin has opened new perspectives in the management of a variety of anemias. Based on current ...
Abstract The characteristics and uses of epoetin alfa ( recombinant human erythropoietin ) are described, and the issues associated with its use are discussed. The use of epoetin alfa was recently ...
It has been 6 years since the first reports of the use of recombinant human erythropoietin for the treatment of renal anemia appeared in the medical literature. During this period, erythropoietin has ...
of these articles, the reader should understand: 1. how advances in recombinant DNA technology have resulted in the commercial availability of recombinant human erythropoietin for the treatment of anemia associated ...
Recombinant human erythropoietin is increasingly used to treat anemia in predialysis patients. Approximately 33-40% of patients ultimately receiving dialysis or a transplant may be eligible ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!